{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T17:18:18Z","timestamp":1784395098981,"version":"3.55.0"},"reference-count":121,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","contraceptionjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.contraception.2011.02.005","type":"journal-article","created":{"date-parts":[[2011,3,30]],"date-time":"2011-03-30T18:18:15Z","timestamp":1301509095000},"page":"4-18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":111,"title":["RETIRED: Labor induction abortion in the second trimester"],"prefix":"10.1016","volume":"84","author":[{"given":"Lynn","family":"Borgatta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Kapp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2011.02.005_bb0005","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1056\/NEJM199408043310502","article-title":"Comparison of intravaginal misoprostol with\u00a0prostaglandin-E(2) for termination of 2nd-trimester pregnancy","volume":"331","author":"Jain","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2011.02.005_bb0010","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0002-9378(96)70270-3","article-title":"A comparison of misoprostol with and without laminaria tents for induction of second-trimester abortion","volume":"175","author":"Jain","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2011.02.005_bb0015","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0029-7844(98)00485-2","article-title":"A comparison of two dosing regimens of intravaginal misoprostol for second-trimester pregnancy termination","volume":"93","author":"Jain","year":"1999","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2011.02.005_bb0020","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1067\/mob.2002.121085","article-title":"The optimization of intravaginal misoprostol dosing schedules in second-trimester pregnancy termination","volume":"186","author":"Dickinson","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2011.02.005_bb0025","first-page":"1","article-title":"Abortion surveillance \u2014 United States, 2004","volume":"56","author":"Strauss","year":"2007","journal-title":"MMWR Surveill Summ"},{"key":"10.1016\/j.contraception.2011.02.005_bb0030","first-page":"1","article-title":"Abortion surveillance \u2014 United States, 2005","volume":"57","author":"Gamble","year":"2008","journal-title":"MMWR Surveill Summ"},{"key":"10.1016\/j.contraception.2011.02.005_bb0035","unstructured":"Socialstyrelsen. Aborter 2005. Stockholm, Sweden; 2006. Report No.: Report: 2006-42-2 (Evidence Grade: III)."},{"issue":"Suppl 2","key":"10.1016\/j.contraception.2011.02.005_bb0040","doi-asserted-by":"crossref","first-page":"S178","DOI":"10.1016\/j.ijgo.2007.09.007","article-title":"Misoprostol for the termination of pregnancy with a live fetus at 13 to 26 weeks","volume":"99","author":"Ho","year":"2007","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.contraception.2011.02.005_bb0045","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ejogrb.2005.10.021","article-title":"Misoprostol versus cervagem for the induction of labour to terminate pregnancy in the second and third trimester: a systematic review","volume":"125","author":"Dodd","year":"2006","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.contraception.2011.02.005_bb0605","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/j.1745-7254.2006.00393.x","article-title":"Multiple Mechanisms involved in oxytocin-induced modulation of myometrial conrtactility","volume":"27","author":"Shmygol","year":"2006","journal-title":"Acta Pharmacol Sin"},{"issue":"31 Suppl","key":"10.1016\/j.contraception.2011.02.005_bb0050","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0968-8080(08)31392-5","article-title":"Misoprostol preferable to ethacridine lactate for abortions at 13\u201320 weeks of pregnancy: Cuban experience","volume":"16","author":"Boza","year":"2008","journal-title":"Reprod Health Matters"},{"key":"10.1016\/j.contraception.2011.02.005_bb0055","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1080\/00016340500345337","article-title":"Randomized study on the effect of adding oxytocin to ethacridine lactate or misoprostol for second-trimester termination of pregnancy","volume":"85","author":"Kelekci","year":"2006","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.contraception.2011.02.005_bb0060","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/j.ajog.2005.02.082","article-title":"A prospective, randomized comparison of vaginal misoprostol versus intra-amniotic prostaglandins for midtrimester termination of pregnancy","volume":"193","author":"Su","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2011.02.005_bb0065","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.contraception.2003.09.006","article-title":"Midtrimester medical termination of pregnancy: a review of 1002 consecutive cases","volume":"69","author":"Ashok","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.02.005_bb0070","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.contraception.2005.04.016","article-title":"A randomized clinical trial of the addition of laminaria to misoprostol and hypertonic saline for second-trimester induction abortion","volume":"72","author":"Borgatta","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.02.005_bb0075","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1097\/01.AOG.0000289577.32274.a5","article-title":"Mifepristone in midtrimester medical abortion: a randomized controlled trial","volume":"110","author":"Kapp","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2011.02.005_bb0080","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/pd.2012","article-title":"The effect of gestational age on the outcome of second-trimester termination of pregnancies for foetal abnormalities","volume":"28","author":"Lo","year":"2008","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.contraception.2011.02.005_bb0085","first-page":"1037","article-title":"Dilation and evacuation for second-trimester genetic pregnancy termination","volume":"75","author":"Shulman","year":"1990","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2011.02.005_bb0090","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1016\/j.ajog.2005.02.064","article-title":"Comparison of perinatal grief after dilation and evacuation or labor induction in second trimester terminations for fetal anomalies","volume":"192","author":"Burgoine","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2011.02.005_bb0095","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1001\/jama.1984.03340310030014","article-title":"Midtrimester abortion. Intra-amniotic instillation of hyperosmolar urea and prostaglandin F2 alpha v dilatation and evacuation","volume":"251","author":"Kafrissen","year":"1984","journal-title":"JAMA"},{"key":"10.1016\/j.contraception.2011.02.005_bb0100","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1046\/j.1471-0528.2003.00044.x-i1","article-title":"Mifepristone and misoprostol versus dilation and evacuation for midtrimester abortion: a pilot randomised controlled trial","volume":"111","author":"Grimes","year":"2004","journal-title":"BJOG"},{"key":"10.1016\/j.contraception.2011.02.005_bb0105","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1067\/mob.2002.123887","article-title":"A comparison of medical induction and dilation and evacuation for second-trimester abortion","volume":"187","author":"Autry","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2011.02.005_bb0110","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/0002-9378(94)90162-7","article-title":"Abortion mortality, United States, 1972 through 1987","volume":"171","author":"Lawson","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2011.02.005_bb0115","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.ajog.2005.09.003","article-title":"Cost-effectiveness of dilation and evacuation versus the induction of labor for second-trimester pregnancy termination","volume":"194","author":"Cowett","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2011.02.005_bb0120","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0020-7292(01)00478-7","article-title":"Laminaria, induced fetal demise and misoprostol in late abortion","volume":"75","author":"Hern","year":"2001","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.contraception.2011.02.005_bb0125","unstructured":"National Abortion Federation Annual Clinical Meeting, Portland, Oregon, April 25, 2009."},{"key":"10.1016\/j.contraception.2011.02.005_bb0130","series-title":"The care of women requesting induced abortion","author":"Royal College of Obstetricians and Gynaecologists","year":"2004"},{"key":"10.1016\/j.contraception.2011.02.005_bb0135","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/j.1471-0528.1996.tb09842.x","article-title":"A comparison of 600 and 200 mg mifepristone prior to second trimester abortion with the prostaglandin misoprostol","volume":"103","author":"Webster","year":"1996","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.contraception.2011.02.005_bb0140","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/j.1471-0528.1993.tb14269.x","article-title":"Induction of 2nd trimester abortion with mifepristone and gemeprost","volume":"100","author":"Thong","year":"1993","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.contraception.2011.02.005_bb0145","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1093\/oxfordjournals.humrep.a137203","article-title":"The use of mifepristone prior to prostaglandin-induced midtrimester-abortion","volume":"5","author":"Urquhart","year":"1990","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2011.02.005_bb0150","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0010-7824(97)00184-4","article-title":"Oral mifepristone 600 mg and vaginal gemeprost for mid-trimester induction of abortion. An open multicenter study","volume":"56","year":"1997","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.02.005_bb0155","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ijgo.2005.11.010","article-title":"Vaginal vs. oral misoprostol for mid-trimester abortion","volume":"92","author":"Nigam","year":"2006","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.contraception.2011.02.005_bb0160","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.contraception.2005.12.004","article-title":"Induction of second trimester abortion (12\u201320 weeks) with mifepristone and misoprostol: a review of 386 consecutive cases","volume":"73","author":"Goh","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.02.005_bb0165","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1479-828X.2006.00646.x","article-title":"Mifepristone- and misoprostol-induced mid-trimester termination of pregnancy: a review of 272 cases","volume":"46","author":"Rose","year":"2006","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.contraception.2011.02.005_bb0170","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0010-7824(01)00219-0","article-title":"Second trimester medical abortion with mifepristone and gemeprost: a review of 956 cases","volume":"64","author":"Tang","year":"2001","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.02.005_bb0175","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.contraception.2008.02.016","article-title":"Late second-trimester abortions induced with mifepristone, misoprostol and oxytocin: a report of 428 consecutive cases","volume":"78","author":"Esteve","year":"2008","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.02.005_bb0180","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1093\/humrep\/dei196","article-title":"A prospective randomized comparison of sublingual and oral misoprostol when combined with mifepristone for medical abortion at 12\u201320 weeks gestation","volume":"20","author":"Tang","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2011.02.005_bb0185","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1111\/j.1471-0528.2004.00222.x","article-title":"A prospective randomised comparison of sublingual and vaginal misoprostol in second trimester termination of pregnancy","volume":"111","author":"Tang","year":"2004","journal-title":"BJOG"},{"key":"10.1016\/j.contraception.2011.02.005_bb0190","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1093\/humrep\/dei037","article-title":"A randomized trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion at 13\u201320 weeks gestation","volume":"20","author":"Hamoda","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2011.02.005_bb0195","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1080\/00016340701505002","article-title":"One or two day mifepristone-misoprostol interval for second trimester abortion","volume":"86","author":"Nilas","year":"2007","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.contraception.2011.02.005_bb0200","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S1472-6483(10)60522-6","article-title":"One- and two-day mifepristone-misoprostol intervals are both effective in medical termination of second- trimester pregnancy","volume":"8","author":"Heikinheimo","year":"2004","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.contraception.2011.02.005_bb0205","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0010-7824(02)00291-3","article-title":"Second trimester abortion by laminaria followed by vaginal misoprostol or intrauterine prostaglandin F2alpha: a randomized trial","volume":"65","author":"Paz","year":"2002","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.02.005_bb0210","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.ajog.2003.09.037","article-title":"Randomized controlled trial of misoprostol for second-trimester pregnancy termination associated with fetal malformation","volume":"190","author":"Akoury","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2011.02.005_bb0215","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S1701-2163(16)30499-6","article-title":"A randomized trial comparing oral misoprostol with intra-amniotic prostaglandin F2alpha for second trimester terminations","volume":"27","author":"Marquette","year":"2005","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.contraception.2011.02.005_bb0220","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S0002-9378(99)70081-5","article-title":"Second-trimester uterine evacuation: a comparison of intra-amniotic (15S)-15-methyl-prostaglandin F2alpha and intravaginal misoprostol","volume":"181","author":"Perry","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2011.02.005_bb0225","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1080\/j.1600-0412.1998.770412.x","article-title":"Second-trimester termination of pregnancy by extra-amniotic prostaglandin F2alpha or endocervical misoprostol. A comparative study","volume":"77","author":"Ghorab","year":"1998","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.contraception.2011.02.005_bb0230","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/S0029-7844(03)00357-0","article-title":"A comparison of oral misoprostol with vaginal misoprostol administration in second-trimester pregnancy termination for fetal abnormality","volume":"101","author":"Dickinson","year":"2003","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2011.02.005_bb0235","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1080\/0144361031000120923","article-title":"Second-trimester pregnancy termination: comparison of three different methods","volume":"23","author":"Makhlouf","year":"2003","journal-title":"J Obstet Gynaecol"},{"key":"10.1016\/j.contraception.2011.02.005_bb0240","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/(SICI)1520-6661(199903\/04)8:2<48::AID-MFM3>3.0.CO;2-F","article-title":"Vaginal misoprostol vs. concentrated oxytocin plus low-dose prostaglandin E2 for second trimester pregnancy termination","volume":"8","author":"Owen","year":"1999","journal-title":"J Matern Fetal Med"},{"key":"10.1016\/j.contraception.2011.02.005_bb0245","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1097\/AOG.0b013e31819dbfe2","article-title":"Uterine rupture in second-trimester misoprostol-induced abortion after cesarean delivery: a systematic review","volume":"113","author":"Goyal","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2011.02.005_bb0250","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000067889","article-title":"High-dose oral misoprostol for mid-trimester pregnancy interruption","volume":"54","author":"Ramin","year":"2002","journal-title":"Gynecol Obstet Invest"},{"issue":"Supplement 1","key":"10.1016\/j.contraception.2011.02.005_bb0255","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.ajog.2005.05.087","article-title":"High-dose vaginal misoprostol versus concentrated oxytocin plus low-dose vaginal misoprostol for midtrimester labor induction: a randomized trial","volume":"193","author":"Nuthalapaty","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2011.02.005_bb0260","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0090-6980(87)90268-1","article-title":"Prostaglandin-induced pregnancy termination: further studies using gemeprost (16,16 dimethyl-trans-delta 2-PGE1 methyl ester) vaginal pessaries in the early second trimester","volume":"34","author":"Cameron","year":"1987","journal-title":"Prostaglandins"},{"key":"10.1016\/j.contraception.2011.02.005_bb0265","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0010-7824(92)90127-F","article-title":"Study of gemeprost alone, dilapan or mifepristone in combination with gemeprost for the termination of 2nd trimester pregnancy","volume":"46","author":"Thong","year":"1992","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.02.005_bb0270","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.1471-0528.1991.tb13441.x","article-title":"Uterine rupture in midtrimester abortion. A complication of gemeprost vaginal pessaries and oxytocin. Case report","volume":"98","author":"Thong","year":"1991","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.contraception.2011.02.005_bb0275","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1479-828X.1996.tb02714.x","article-title":"A randomized trial of 2 regimens for the administration of vaginal prostaglandins (gemeprost) for the induction of midtrimester abortion","volume":"36","author":"Armatage","year":"1996","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.contraception.2011.02.005_bb0280","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0029-7844(97)00491-2","article-title":"A comparison between two doses of intravaginal misoprostol and gemeprost for induction of second-trimester abortion","volume":"90","author":"Nuutila","year":"1997","journal-title":"Obstetrics and Gynecology"},{"key":"10.1016\/j.contraception.2011.02.005_bb0285","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/13625180802360865","article-title":"Sublingual misoprostol 100 microgram versus 200 microgram for second trimester abortion: a randomized trial","volume":"24","author":"Caliskan","year":"2009","journal-title":"Eur J Contracept Repro Health Care"},{"key":"10.1016\/j.contraception.2011.02.005_bb0290","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0010-7824(98)00099-7","article-title":"Vaginal misoprostol compared with vaginal gemeprost in termination of second trimester pregnancy \u2014 a randomized trial","volume":"58","author":"Wong","year":"1998","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.02.005_bb0295","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1080\/01443610600811383","article-title":"Misoprostol (alone) in second trimester terminations of pregnancy: as effective as Gemeprost?","volume":"26","author":"Nor Azlin","year":"2006","journal-title":"J Obstet Gynaecol"},{"key":"10.1016\/j.contraception.2011.02.005_bb0300","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1093\/oxfordjournals.humrep.a137927","article-title":"The abortifacient effect of misoprostol in the second trimester. A randomized comparison with gemeprost in patients pre-treated with mifepristone (RU486)","volume":"8","author":"el-Rafaey","year":"1993","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2011.02.005_bb0305","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/oxfordjournals.humrep.a135965","article-title":"Induction of abortion in the second trimester by a combination of misoprostol and mifepristone: a randomized comparison between two misoprostol regimens","volume":"10","author":"el-Refaey","year":"1995","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2011.02.005_bb0310","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0010-7824(96)00061-3","article-title":"Misoprostol is as effective as gemeprost in termination of second trimester pregnancy when combined with mifepristone: a randomised comparative trial","volume":"53","author":"Ho","year":"1996","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.02.005_bb0315","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1046\/j.1471-0528.2002.01462.x","article-title":"A randomised study of misoprostol and gemeprost in combination with mifepristone for induction of abortion in the second trimester of pregnancy","volume":"109","author":"Bartley","year":"2002","journal-title":"Bjog-An International Journal of Obstetrics and Gynaecology"},{"key":"10.1016\/j.contraception.2011.02.005_bb0320","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/00006250-199102000-00028","article-title":"Mid-second-trimester labor induction: concentrated oxytocin compared with prostaglandin E2 vaginal suppositories","volume":"77","author":"Winkler","year":"1991","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2011.02.005_bb0325","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/S0002-9378(12)80049-4","article-title":"Midtrimester pregnancy termination: a randomized trial of prostaglandin E2 versus concentrated oxytocin","volume":"167","author":"Owen","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2011.02.005_bb0330","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0301-2115(95)02548-0","article-title":"Second trimester pregnancy termination including fetal death: comparison of five different methods","volume":"69","author":"Yapar","year":"1996","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.contraception.2011.02.005_bb0335","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.contraception.2007.09.007","article-title":"Second-trimester pregnancy termination with 600-microg vs. 400-microg vaginal misoprostol and systematic curettage postexpulsion: a randomized trial","volume":"77","author":"Carbonell","year":"2008","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.02.005_bb0340","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1447-0756.2001.tb01235.x","article-title":"Second trimester pregnancy termination: a comparison of 600 and 800 micrograms of intravaginal misoprostol","volume":"27","author":"Herabutya","year":"2001","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.contraception.2011.02.005_bb0345","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.contraception.2004.01.010","article-title":"Vaginal misoprostol 800 microg every 12 h for second-trimester abortion","volume":"70","author":"Carbonell","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.02.005_bb0350","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/humrep\/15.3.709","article-title":"A comparison of two regimens of intravaginal misoprostol for termination of second trimester pregnancy: a randomized comparative trial","volume":"15","author":"Wong","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2011.02.005_bb0355","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1159\/000088048","article-title":"Efficacy of two regimens of misoprostol for early second-trimester pregnancy termination","volume":"20","author":"Guix","year":"2005","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.contraception.2011.02.005_bb0360","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1159\/000292634","article-title":"Pregnancy interruption by vaginal misoprostol","volume":"36","author":"Bugalho","year":"1993","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.contraception.2011.02.005_bb0365","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1093\/humrep\/15.10.2205","article-title":"Randomized comparison of vaginal (200 mu g every 3 h) and oral (400 mu g every 3 h) misoprostol when combined with mifepristone in termination of second trimester pregnancy","volume":"15","author":"Ngai","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2011.02.005_bb0370","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0029-7844(97)00419-5","article-title":"Vaginal misoprostol compared with oral misoprostol in termination of second-trimester pregnancy","volume":"90","author":"Ho","year":"1997","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2011.02.005_bb0375","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1479-828X.2001.tb01318.x","article-title":"A randomised trial of oral versus vaginal administration of misoprostol for the purpose of mid-trimester termination of pregnancy","volume":"41","author":"Gilbert","year":"2001","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.contraception.2011.02.005_bb0380","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1067\/mob.2002.127461","article-title":"A randomized controlled trial comparing two protocols for the use of misoprostol in midtrimester pregnancy termination","volume":"187","author":"Bebbington","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2011.02.005_bb0385","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/humrep\/17.2.332","article-title":"Pharmacokinetics of different routes of administration of misoprostol","volume":"17","author":"Tang","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2011.02.005_bb0390","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00404-007-0374-9","article-title":"Randomized comparison of second trimester pregnancy termination utilizing saline moistened or dry misoprostol","volume":"276","author":"Yilmaz","year":"2007","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.contraception.2011.02.005_bb0395","doi-asserted-by":"crossref","unstructured":"von Hertzen H, Piaagio G, Wojdyla D, et al. Comparison of vaginal and sublingual misoprostol for second trimester abortion: randomized controlled equivalence trial. Hum Reprod 24:106\u201312 (Evidence Grade: I).","DOI":"10.1093\/humrep\/den328"},{"key":"10.1016\/j.contraception.2011.02.005_bb0400","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.contraception.2009.12.018","article-title":"Randomized trial of buccal versus vaginal misoprostol for induction of second trimester abortion","volume":"81","author":"Ellis","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.02.005_bb0405","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1067\/S0002-9378(03)00659-8","article-title":"A randomized comparison of two regimens of misoprostol for second-trimester pregnancy termination","volume":"189","author":"Feldman","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2011.02.005_bb0410","first-page":"243","article-title":"Prospective comparison of dilapan and laminaria for pretreatment of the cervix in 2nd-trimester induction abortion","volume":"72","author":"Blumenthal","year":"1988","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2011.02.005_bb0415","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0002-9378(16)33030-7","article-title":"Laminaria use in midtrimester abortions induced by intra-amniotic prostaglandin-f2-alpha with urea and intravenous oxytocin","volume":"134","author":"Strauss","year":"1979","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2011.02.005_bb0420","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S0029-7844(98)00194-X","article-title":"Second trimester abortion using prostaglandin E-2 suppositories with or without intracervical Laminaria japonica: a randomized study","volume":"92","author":"Atlas","year":"1998","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2011.02.005_bb0425","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0090-6980(75)80095-5","article-title":"Laminaria augmentation of intra-amniotic Pgf2Alpha for midtrimester pregnancy termination","volume":"10","author":"Stubblefield","year":"1975","journal-title":"Prostaglandins"},{"key":"10.1016\/j.contraception.2011.02.005_bb0430","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0090-6980(82)90053-3","article-title":"Termination of 2nd trimester pregnancy with laminaria and intramuscular 16-phenoxy-omega-17,18,19,20 tetranor Pge2 methylsulfonylamide (Sulprostone) \u2014 a randomized study","volume":"23","author":"Karim","year":"1982","journal-title":"Prostaglandins"},{"key":"10.1016\/j.contraception.2011.02.005_bb0435","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0090-6980(91)90054-J","article-title":"Late midtrimester medical pregnancy terminations \u2014 3 different procedures with prostaglandin-F2-alpha and laminaria tents","volume":"41","author":"Papageorgiou","year":"1991","journal-title":"Prostaglandins"},{"key":"10.1016\/j.contraception.2011.02.005_bb0440","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/j.1471-0528.1995.tb11404.x","article-title":"Reducing the induction to abortion interval in termination of 2nd trimester pregnancies \u2014 a comparison of mifepristone with laminaria tent","volume":"102","author":"Ho","year":"1995","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.contraception.2011.02.005_bb0445","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.contraception.2007.07.008","article-title":"Mifepristone versus laminaria: a randomized controlled trial of cervical ripening in midtrimester termination","volume":"76","author":"Prairie","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.02.005_bb0450","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0010-7824(92)90127-F","article-title":"A study of gemeprost alone, dilapan or mifepristone in combination with gemeprost for the termination of 2nd trimester pregnancy","volume":"46","author":"Thong","year":"1992","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.02.005_bb0455","first-page":"83","article-title":"Evaluation of combination RU 486-laminaria tents-misoprostol-peridural anesthesia in second and third trimester induced abortions","volume":"27","author":"Hoffer","year":"1998","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"key":"10.1016\/j.contraception.2011.02.005_bb0460","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0010-7824(82)90076-2","article-title":"Mid-trimester pregnancy termination by intra-vaginal administration of prostaglandin-E2","volume":"26","author":"Surrago","year":"1982","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.02.005_bb0465","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/0002-9378(77)90639-1","volume":"129","year":"1977","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2011.02.005_bb0470","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0002-9378(15)33120-3","article-title":"Five thousand consecutive saline inductions","volume":"116","author":"Kerenyi","year":"1973","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2011.02.005_bb0475","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1136\/bmj.1.6022.1373","article-title":"Comparison of intra-amniotic prostaglandin F2 alpha and hypertonic saline for induction of second-trimester abortion","volume":"1","author":"Anonymous","year":"1976","journal-title":"Br Med J"},{"key":"10.1016\/j.contraception.2011.02.005_bb0480","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0029-7844(02)02213-5","article-title":"Effect of oral misoprostol after second-trimester delivery: a randomized, blinded study","volume":"100","author":"Leader","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2011.02.005_bb0485","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.contraception.2007.06.010","article-title":"Intervention rates for placental removal following induction abortion with misoprostol","volume":"76","author":"Green","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.02.005_bb0490","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/0002-9378(89)90460-2","article-title":"Management of the 3rd stage of labor in pregnancies terminated by prostaglandin-E2","volume":"160","author":"Kirz","year":"1989","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2011.02.005_bb0495","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0301-2115(95)02365-8","article-title":"Uterine rupture during second trimester termination of pregnancy using mifepristone and a prostaglandin","volume":"65","author":"Phillips","year":"1996","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.contraception.2011.02.005_bb0500","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.ajog.2005.03.057","article-title":"Outcomes of second-trimester pregnancy terminations with misoprostol: comparing 2 regimens","volume":"193","author":"Edwards","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2011.02.005_bb0505","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00404-006-0225-0","article-title":"Silent rupture of unscarred uterus: an unusual presentation at second trimester abortion","volume":"275","author":"Malhotra","year":"2007","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.contraception.2011.02.005_bb0510","first-page":"296","article-title":"Fetal intracardiac potassium-chloride injection to avoid the hopeless resuscitation of an abnormal abortus. 1. Clinical issues","volume":"80","author":"Isada","year":"1992","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2011.02.005_bb0515","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0301-2115(00)00445-0","article-title":"Uterine rupture in second trimester abortion in a grand multiparous woman. A complication of misoprostol and oxytocin","volume":"96","author":"Al-Hussaini","year":"2001","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.contraception.2011.02.005_bb0520","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S0029-7844(01)01546-0","article-title":"Uterine rupture during second-trimester abortion associated with misoprostol","volume":"98","author":"Berghahn","year":"2001","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2011.02.005_bb0525","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/S0029-7844(99)00335-X","article-title":"Separation of cesarean scar during second-trimester intravaginal misoprostol abortion","volume":"94","author":"Chen","year":"1999","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2011.02.005_bb0530","first-page":"371","article-title":"Uterine rupture on unscarred uterus following labor induction for 2nd trimester termination of pregnancy with oral misoprostol: conservative management","volume":"31","author":"Letourneur","year":"2002","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"key":"10.1016\/j.contraception.2011.02.005_bb0535","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1159\/000087115","article-title":"Uterine rupture during second trimester abortion with misoprostol","volume":"20","author":"Nayki","year":"2005","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.contraception.2011.02.005_bb0540","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ijgo.2004.05.019","article-title":"Rupture in an unscarred uterus during second trimester pregnancy termination with mifepristone and misoprostol","volume":"87","author":"Bagga","year":"2004","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.contraception.2011.02.005_bb0545","first-page":"23","article-title":"Misoprostol for termination of mid-trimester post-caesarean pregnancy","volume":"47","author":"Bhattacharjee","year":"2007","journal-title":"ANZ J Obstet Gynaecol"},{"key":"10.1016\/j.contraception.2011.02.005_bb0550","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.contraception.2005.09.007","article-title":"Termination of pregnancy in patients with previous cesarean section","volume":"73","author":"Mazouni","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.02.005_bb0555","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0020-7292(03)00312-6","article-title":"Induction of labor with vaginal misoprostol for second trimester termination of pregnancy in the scarred uterus","volume":"83","author":"Herabutya","year":"2003","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.contraception.2011.02.005_bb0560","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/01.AOG.0000128947.31887.94","article-title":"Vaginal misoprostol versus concentrated oxytocin and vaginal PGE2 for second-trimester labor induction","volume":"104","author":"Ramsey","year":"2004","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2011.02.005_bb0565","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1471-0528.2007.01639.x","article-title":"Intracardiac injection of potassium chloride as method for feticide: experience from a single UK tertiary centre","volume":"115","author":"Pasquini","year":"2008","journal-title":"BJOG"},{"key":"10.1016\/j.contraception.2011.02.005_bb0570","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ijoa.2004.04.009","article-title":"Maternal cardiac arrest associated with attempted fetal injection of potassium chloride","volume":"13","author":"Coke","year":"2004","journal-title":"Int J Obstet Anesth"},{"key":"10.1016\/j.contraception.2011.02.005_bb0575","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1046\/j.1471-0528.2003.02217.x","article-title":"The use of lidocaine for fetocide in late termination of pregnancy","volume":"110","author":"Senat","year":"2003","journal-title":"BJOG"},{"key":"10.1016\/j.contraception.2011.02.005_bb0580","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0029-7844(00)01148-0","article-title":"Digoxin to facilitate late second-trimester abortion: a randomized, masked, placebo-controlled trial","volume":"97","author":"Jackson","year":"2001","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2011.02.005_bb0585","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.contraception.2007.10.011","article-title":"Effectiveness and safety of digoxin to induce fetal demise prior to second-trimester abortion","volume":"77","author":"Molaei","year":"2008","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.02.005_bb0590","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1067\/mob.2000.105438","article-title":"Safety of intra-amniotic digoxin administration before late second-trimester abortion by dilation and evacuation","volume":"182","author":"Drey","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2011.02.005_bb0595","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0029-7844(99)00273-2","article-title":"Effect of causing fetal cardiac asystole on second-trimester abortion","volume":"94","author":"Elimian","year":"1999","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2011.02.005_bb0600","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1159\/000080157","article-title":"Second- and third-trimester therapeutic terminations of pregnancy in cases with complete placenta previa \u2014 does feticide decrease postdelivery maternal hemorrhage?","volume":"19","author":"Ruano","year":"2004","journal-title":"Fetal Diagn Ther"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782411000576?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782411000576?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T22:44:49Z","timestamp":1761432289000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782411000576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":121,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0010782411000576"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2011.02.005","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RETIRED: Labor induction abortion in the second trimester","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2011.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}